<DOC>
	<DOCNO>NCT03060486</DOCNO>
	<brief_summary>Blood contamination , apical microleakage , root canal preparation major problem endodontics . The purpose investigation evaluate hemostatic property sulfonic/sulfuric acid solution use root canal therapy teeth irreversible pulpitis .</brief_summary>
	<brief_title>A New Approach Controlling Hemostasis During Canal Treatment : Pilot Study</brief_title>
	<detailed_description>A new device ( HYBENX® ) develop purpose destroy dental biofilm . The material contain concentrate aqueous mixture hydroxybenzenesulfonic acid ( 37 % ) hydroxymethoxybenzene acid ( 23 % ) , sulfuric acid ( 28 % ) , water ( 12 % ) . The investigator plan clinical microbiological study use decontaminant device order destroy dental biofilm root canal case irreversible pulpitis . The ability decontaminant device immediately stop bleed canal instrumentation find accidentally procedure still unpublished trial . Due fact , investigator interest evaluate coagulation property material . Therefore , aim prospective study describe new approach obtain hemostasis root canal therapy use sulfonic/sulfuric acid solution . A total 15 teeth irreversible acute pulpitis include study . After manual mechanical instrumentation root canal , sterile paper point introduce canal , first score give base blood quantity . The solution use irrigate bleed root canal ; second sterile paper point introduce , score assess . The null hypothesis difference root canal bleeding use solution ( ⎧=0 ) Results : The Wilcoxon signed-rank test show statistically significant decrease root bleed score application sulfonic/sulfuric acid solution ( P &lt; .0001 ) Conclusions : The use material seem aid root canal treatment teeth irreversible pulpitis copious root canal bleeding .</detailed_description>
	<mesh_term>Hemostatics</mesh_term>
	<criteria>tooth affect irreversible pulpitis , singlerooted teeth associate healthy periodontium , physiologic sulcus depth ( &lt; 3 mm ) , absence bleed probe involve teeth . patient systemic disease use anticoagulant , antibiotic , antiinflammatory therapy last 30 day , patient allergy sulfur form , pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>